• Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • You are here:
  • Home
  • Insights
  • Natural ingredients, inherently safe?

Natural ingredients, inherently safe?

In the April 2019 edition of the journal Cosmetics & Toiletries, the Executive Director of the Cosmetics Ingredient Review (CIR) in Washington DC, Dr. Bart Heldreth, addresses the myth of the perceived greater safety of natural versus synthetic ingredients. The CIR Expert Panel reviews every year a list of substances, including everything from honey to olive leaf extract, selected based on their frequency of use in consumer products. While botanical ingredients, such as olive leaf extract, often connote safety to some consumers, product developers know that there is nothing intrinsically safe about chemicals from natural sources. Performing a thorough safety assessment of botanical or botanically sourced ingredients is therefore just as important as reviewing the safety of synthetic ingredients.

Dr. Heldreth illustrated the point by describing the assessment carried out on three methylxa­nthine ingredients – caffeine, theobromine and theophylline. Although of natural origin, a review of all available safety data revealed conflicting results for these substances with regard to genotoxicity, as well as some findings in development and reproductive studies. Closer evaluation of the data and an assessment of consumer exposure showed that the maximum exposure from typical use of a cosmetic product is well below that which could cause consumer harm. As such, the CIR Expert Panel concluded that the three methylxa­nthine ingredients are safe in cosmetics under the present practices of use and concentration described in the safety assessment. Nevertheless, the point is made that a thorough safety assessment should always be conducted, no matter whether the ingredient is of natural or synthetic origin. Once again, the dose makes the poison.

Contact
  • Dr. Francesca Tencalla

    Dr. Francesca Tencalla

MORE INSIGHTS
  • Application of in silico and TTC based decision tree for safety assessment of botanicals

  • Adopting New Approach Methodologies (NAM) in the next generation risk assessment (NGRA)

  • Update on the development of a regulatory framework for developmental neurotoxicity testing with specific focus on non-animal testing approaches

  • Evaluation of in vitro assays for the assessment of the skin sensitisation hazard of functional polysiloxanes and silanes

  • Read-across – State of the art and next level!

Severity of eye effects caused by accidental exposure to detergent and cleaning products

Previous thumb

Mutagenicity assessment of drug impurities according to the ICH M7 (R1) guideline and the role of expert review

Next thumb
Scroll

 

ToxMinds are specialised in ensuring product safety and compliance.

We are passionate about toxicology and how emerging scientific developments can be utilised to support our customers in bringing safe, regulatory compliant and sustainable products to the marketplace.

 

 

 

 

Belgium
ToxMinds BV
Avenue de Tervueren 188A, bte 12
B-1150 Brussels Belgium

VAT BE 0877.628.383

Tel: +32 (0)2 762 9145
Email: contact us

 

 

 

 

India
ToxMinds India Consulting Pvt. Ltd.
Unit 305, 3rd Floor, Brigade IRV Centre, Whitefield, Bangalore-560066, India

 

Tel: +91 804 204 19 20
Email: contact us

 

 

 

 

 

LinkedIN
Copyright and disclaimer | Data privacy
  • Home
  • Industries
  • Services
  • Team
  • Insights
  • Careers
  • Contact
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok